@prefix : <http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis> .

<http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis> rdf:type owl:Ontology ;
                                                                               owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                           mp: ;
                                                                               rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255512/"^^xsd:anyURI ;
                                                                               rdfs:label "Pamidronic acid and Optic Neuritis"^^xsd:Literal ;
                                                                               owl:versionInfo "draft-v0.95-20211112"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


#################################################################
#    Data properties
#################################################################

###  http://purl.org/mp/citation
mp:citation rdf:type owl:DatatypeProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#DiscussionAndConclusion
:DiscussionAndConclusion rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Conclusion ,
                                  OpenPVSignal:Discussion ;
                         OpenPVSignal:has_content """Case reports in VigiBase suggest that there is a signal for the association of pamidronic acid and optic neuritis. While most of the cases have pamidronic acid as the sole suspected drug, dechallenge information is lacking as can be the case with a drug administered intravenously and periodically. Time to onset is reported in only two reports but both displayed a close association between the onset of the reaction and the last administration of pamidronic acid.

There have been two literature reports of optic neuritis in association with pamidronic acid. The product information indicates that pamidronic acid can be associated with other inflammatory ocular effects such as conjunctivitis, scleritis, iridocyclitis, iritis and uveitis so it would not be surprising if pamidronic acid can be associated with optic neuritis. In addition, the number of reports of optic neuritis for pamidronic acid and other bisphosphonates also suggests that optic neuritis may occur at a similar frequency to that of other inflammatory ocular reactions.

In conclusion, while it is possible that optic neuritis could arise from other causes in this series of reports, the case reports currently in VigiBase are suggestive that pamidronic acid could be the causative agent.
""" ;
                         rdfs:label "Discussion and conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Dr_Ian_Boyd
:Dr_Ian_Boyd rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Author ;
             OpenPVSignal:has_first_name "Ian" ;
             OpenPVSignal:has_last_name "Boyd" ;
             rdfs:label "Dr Ian Boyd" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#IC025OfPamindronicAcidAndOpticNeuritis
:IC025OfPamindronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                        OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                        OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                        OpenPVSignal:refers_to_information_component :ICValueOfPamindronicAcidAndOpticNeuritis ;
                                        OpenPVSignal:has_value 0.35 ;
                                        OpenPVSignal:refers_to_number_of_reports 11 ;
                                        rdfs:label "IC025 of pamindronic acid and optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ICValueOfPamindronicAcidAndOpticNeuritis
:ICValueOfPamindronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                          OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                          OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                          OpenPVSignal:has_value 1.32 ;
                                          OpenPVSignal:refers_to_number_of_reports 11 ;
                                          rdfs:label "IC value of pamindronic acid and optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#IntroductionContent
:IntroductionContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Introduction ;
                     mp:references :ref1 ,
                                   :ref2 ,
                                   :ref3 ,
                                   :ref4 ;
                     OpenPVSignal:has_content """Introduction
Pamidronic acid (disodium pamidronate) is a potent inhibitor of osteoclastic bone resorption. It binds strongly to hydroxyapatite crystals and inhibits the formation and dissolution of these crystals in vitro. Inhibition of osteoclastic bone resorption in vivo may be at least partly due to binding of the drug to the bone mineral.
Pamidronate suppresses the accession of osteoclast precursors onto the bone. However, the local and direct antiresorptive effect of bone- bound bisphosphonate appears to be the predominant mode of action in vitro and in vivo.1
Pamidronic acid is indicated in the treatment of conditions associated with increased osteoclast activity including tumour-induced hypercalcaemia, osteolytic lesions and bone pain in patients with bone metastases associated with breast cancer or multiple myeloma and Pagetâ€™s disease of bone.

Ocular adverse reactions which have been reported include conjunctivitis (common), uveitis (uncommon), scleritis, episcleritis and xanthopsia (very rare) and orbital inflammation (unknown frequency).1

Optic neuritis is a common inflammatory disease of the optic nerve.2 It may cause sudden, reduced vision in the affected eye. The exact cause of optic neuritis is unknown. Conditions that have been linked with optic neuritis include autoimmune diseases, bacterial, fungal, viral and respiratory infections and multiple sclerosis.3 A number of drugs have been implicated in the development of optic neuritis including ethambutol in particular as well as linezolid, amiodarone and cGMP- specific phosphodiesterase type five inhibitors.4""" ;
                     rdfs:label "Introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#MechanismOfPamindronicAcid
:MechanismOfPamindronicAcid rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Mechanism ;
                            mp:references :ref1 ;
                            OpenPVSignal:has_content "Pamidronic acid (disodium pamidronate) is a potent inhibitor of osteoclastic bone resorption. It binds strongly to hydroxyapatite crystals and inhibits the formation and dissolution of these crystals in vitro. Inhibition of osteoclastic bone resorption in vivo may be at least partly due to binding of the drug to the bone mineral. Pamidronate suppresses the accession of osteoclast precursors onto the bone. However, the local and direct antiresorptive effect of bone-bound bisphosphonate appears to be the predominant mode of action in vitro and in vivo.1" ;
                            rdfs:label "Mechanism of pamindronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Pamindronic_acid_and_opti_neuritis
:Pamindronic_acid_and_opti_neuritis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Pharmacovigilance_Signal_Report ;
                                    OpenPVSignal:refers_to_author :Dr_Ian_Boyd ;
                                    OpenPVSignal:refers_to_signal :pvSignal ;
                                    OpenPVSignal:has_creation_date "01/11/2014" ;
                                    OpenPVSignal:has_overall_conclusion "causal association most probable" ;
                                    rdfs:label "Pamindronic acid and optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 88 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient10
:Patient10 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient11
:Patient11 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 12 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 65 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 83 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 65 ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ReportsInVigibase
:ReportsInVigibase rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Free_text_reporting_element ;
                   OpenPVSignal:has_content """As of 1 October 2013 there are 11 Individual Case Safety Reports (ICSRs) of optic neuritis in association with pamidronic acid in the WHO Global ICSR Database, VigiBaseÂ®. The association has an IC value of 1.32 with an IC025 value of 0.35. The reports were submitted from the US (eight cases), Australia, Canada and New Zealand (one case each). The patients ranged in age from 12 to 88 years with a median of 65 years in the five cases in which this information was provided. In the 10 cases which provided the information, the gender distribution was eight females and two males.
Pamidronic acid was the only drug suspected in seven cases while the other four cases had another bisphosphonate, zoledronic acid, as a suspected drug. Four of the cases had no concomitant drugs reported while in the other six cases, the number of concomitant drugs ranged from three to 28. These indicated a population with considerable morbidity including cancer, depression, hypertension, infection and the requirement for treatment of pain, acid suppression and assistance with sleeping.
Pamidronic acid was reported to have been administered intravenously, as expected, in the eight cases which provided this information. The indication for use was included in seven reports and included multiple myeloma (two cases), breast cancer, joint pain and osteoporosis (one case each) Time to onset was reported with clarity in only two of the reports and ranged from the same day that the drug was most recently administered to one day after admi- nistration. For a drug which is administered once every three or four weeks, as it is in the treatment of bone metastases which is the indication in the majority of reports, time to onset is most meaningful when related to the most recent administration. Of the 10 reports in which the outcome was stated, it was recovered, recovering or recovered with sequelae in four cases, not recovered in two cases and the outcome was fatal in the remaining four cases. Four of the reports listed a large number of reactions which described a seriously ill population. Other ocular reactions are also described. In five cases, blindness or visual impairment was reported and this may be regarded as a symptom of optic neuritis. In one other case, iritis was reported and in the remaining case, optic ischaemic neuropathy was reported. Three of the four cases in which the outcome was fatal had a large number of reactions reported including cancer progression which was the likely cause of death in these cases.""" ;
                   rdfs:label "Reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#StackAndTarr
:StackAndTarr rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Literature_information ;
              OpenPVSignal:has_content "Stack and Tarr reported three cases of optic neuritis and uveitis in association with bisphosphonates, one case with alendronate and the other two cases with pamidronic acid.6" ;
              rdfs:label "Stack and Tarr" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#SummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content """Pamidronic acid (disodium pamidronate) is a potent inhibitor of osteoclastic bone resorption. The drug is indicated to treat conditions associated with increased osteoclast activity including tumour-induced hypercalcaemia, osteolytic lesions and bone pain in patients with bone metastases associated with breast cancer or multiple myeloma and Pagetâ€™s disease of bone. In the WHO Global Individual Case Safety Report (ICSR) Database, VigiBaseÂ® there are as of October 2013, 11 reports of optic neuritis in association with pamidronic acid. The association has an IC value of 1.32 with an IC025 value of
0.35.	The reports are from the United States, Australia, Canada and New Zealand. Of the 10 reports in which the outcome was stated, it was recovered, recovering or recovered with sequelae in four cases, not recovered in two cases and the outcome was fatal in the remaining four cases. Drug withdrawal was unclear in some cases but for a drug which is administered once every three or four weeks, drug withdrawal is not a meaningful parameter. There have been two literature reports of optic neuritis in association with pamidronic acid. The product information indicates that pamidronic acid can be associated with other inflammatory ocular effects.""" ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#acetylsalicylicAcid
:acetylsalicylicAcid rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "A01AD05" ,
                                               "B01AC06" ,
                                               "B01AC56" ,
                                               "C10BX01" ,
                                               "C10BX02" ,
                                               "C10BX04" ,
                                               "C10BX05" ,
                                               "C10BX06" ,
                                               "C10BX08" ,
                                               "M01BA03" ,
                                               "N02BA01" ,
                                               "N02BA51" ,
                                               "N02BA71" ;
                     rdfs:label "acetylsalicylic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#alendronic_acid
:alendronic_acid rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "M05BA04" ;
                 rdfs:label "alendronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#allopurinol
:allopurinol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "M04AA01" ,
                                       "M04AA51" ;
             rdfs:label "allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#alprazolam
:alprazolam rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N05BA12" ;
            rdfs:label "alprazolam" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#amiodarone
:amiodarone rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C01BD01" ;
            rdfs:label "amiodarone" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#amitriptyline
:amitriptyline rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "N06AA09" ,
                                         "N06CA01" ;
               rdfs:label "amitriptyline" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#amlodipine
:amlodipine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA01" ,
                                      "C08GA02" ,
                                      "C09BB03" ,
                                      "C09BB04" ,
                                      "C09BB07" ,
                                      "C09BX01" ,
                                      "C09DB01" ,
                                      "C09DB02" ,
                                      "C09DB04" ,
                                      "C09DB05" ,
                                      "C09DB06" ,
                                      "C09DB07" ,
                                      "C09DX01" ,
                                      "C09DX03" ,
                                      "C09XA53" ,
                                      "C09XA54" ,
                                      "C10BX03" ,
                                      "C10BX07" ,
                                      "C10BX09" ,
                                      "C10BX11" ;
            rdfs:label "amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#autoimmune_disorder
:autoimmune_disorder rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_MedDRA_code 10061664 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Autoimmune disorder" ;
                     rdfs:label "autoimmune disorder" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#bacterialInfection
:bacterialInfection rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "S05" ;
                    OpenPVSignal:has_MedDRA_code 10060945 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Bacterial infection" ;
                    rdfs:label "bacterial infection" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#blindness
:blindness rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "H54" ;
           OpenPVSignal:has_MedDRA_code 10005169 ;
           OpenPVSignal:has_MedDRA_prefered_term "Blindness" ;
           rdfs:label "blindness" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#boneMetastases
:boneMetastases rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Indication ;
                OpenPVSignal:has_ICD_code "C79.51" ;
                OpenPVSignal:has_MedDRA_code 10027452 ;
                OpenPVSignal:has_MedDRA_prefered_term "Metastases to bone" ;
                rdfs:label "bone metastases" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#bonePain
:bonePain rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Indication ;
          OpenPVSignal:has_ICD_code "G4763" ;
          OpenPVSignal:has_MedDRA_code 10006002 ;
          OpenPVSignal:has_MedDRA_prefered_term "Bone pain" ;
          rdfs:label "bone pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#breastCancer
:breastCancer rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Indication ;
              OpenPVSignal:has_ICD_code "A49.9" ;
              OpenPVSignal:has_MedDRA_code 10006187 ;
              OpenPVSignal:has_MedDRA_prefered_term "Breast cancer" ;
              rdfs:label "breast cancer" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#celecoxib
:celecoxib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G01AE10" ,
                                     "L01XX33" ,
                                     "M01AH01" ;
           rdfs:label "celecoxib" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#clodronic_acid
:clodronic_acid rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "M05BA02" ;
                rdfs:label "clodronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#clonazepam
:clonazepam rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AE01" ;
            rdfs:label "clonazepam" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#clonidine
:clonidine rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02AC01" ,
                                     "C02LC01" ,
                                     "C02LC51" ,
                                     "N02CX02" ,
                                     "S01EA04" ;
           rdfs:label "clonidine" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#conditions_that_cause_optic_neuritis
:conditions_that_cause_optic_neuritis rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Warning_Information ;
                                      OpenPVSignal:refers_to_adverse_effect :bacterialInfection ,
                                                                            :fungalInfection ,
                                                                            :multipleSclerosis ,
                                                                            :opticNeuritis ,
                                                                            :respiratoryInfection ,
                                                                            :viralInfection ;
                                      mp:references :ref3 ;
                                      OpenPVSignal:has_content "Conditions that have been linked with optic neuritis include autoimmune diseases, bacterial, fungal, viral and respiratory infections and multiple sclerosis.3" ;
                                      rdfs:label "conditions that cause optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#conjunctivitis
:conjunctivitis rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "H1031" ;
                OpenPVSignal:has_MedDRA_code 10010741 ;
                OpenPVSignal:has_MedDRA_prefered_term "Conjunctivitis" ;
                rdfs:label "conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#desGroitesReport
:desGroitesReport rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Literature_information ;
                  OpenPVSignal:has_content "Des Grottes et al described a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis.5 The authors noted that this possible complication had never been previously reported and, since the patient had a history of porphyria, it suggested that bisphosphonates should be administered cautiously in patients with this disease" ;
                  rdfs:label "  des groites report" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#dexamethasone
:dexamethasone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A01AC02" ,
                                         "C05AA09" ,
                                         "D07AB19" ,
                                         "D07CB04" ,
                                         "D07XB05" ,
                                         "D10AA03" ,
                                         "H02AB02" ,
                                         "R01AD03" ,
                                         "R01AD53" ,
                                         "S01BA01" ,
                                         "S01CA01" ,
                                         "S01CB01" ,
                                         "S02BA06" ,
                                         "S02CA06" ,
                                         "S03BA01" ,
                                         "S03CA01" ;
               rdfs:label "dexamethasone" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#duloxetine
:duloxetine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AX21" ;
            rdfs:label "duloxetine" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#episcleritis
:episcleritis rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "H15119" ;
              OpenPVSignal:has_MedDRA_code 10015084 ;
              OpenPVSignal:has_MedDRA_prefered_term "Episcleritis" ;
              rdfs:label "episcleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#esomeprazole
:esomeprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC05" ,
                                        "A02BD06" ,
                                        "M01AE52" ;
              rdfs:label "esomeprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ethambutol
:ethambutol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "J04AK02" ;
            rdfs:label "ethambutol" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#etidronic_acid
:etidronic_acid rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "M05BA01" ;
                rdfs:label "etidronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#fatality
:fatality rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R99" ;
          OpenPVSignal:has_MedDRA_code 10011906 ;
          OpenPVSignal:has_MedDRA_prefered_term "death" ;
          rdfs:label "fatality" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#finasteride
:finasteride rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "D11AX10" ,
                                       "G04CA51" ,
                                       "G04CB01" ;
             rdfs:label "finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#fungalInfection
:fungalInfection rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "B369" ;
                 OpenPVSignal:has_MedDRA_code 10017533 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Fungal infection" ;
                 rdfs:label "fungal infection" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#furosemide
:furosemide rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C03CA01" ,
                                      "C03CB01" ,
                                      "C03EB01" ,
                                      "G01AE10" ;
            rdfs:label "furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#headache
:headache rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R51" ;
          OpenPVSignal:has_MedDRA_code 10019211 ;
          OpenPVSignal:has_MedDRA_prefered_term "Headache" ;
          rdfs:label "headache" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#hydrochlorothiazide
:hydrochlorothiazide rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "C03AA03" ,
                                               "C03AB03" ,
                                               "C03AX01" ,
                                               "C03EA01" ,
                                               "C09DX01" ,
                                               "C09DX03" ,
                                               "C09XA52" ,
                                               "C09XA54" ,
                                               "G01AE10" ;
                     rdfs:label "hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#hypercalcaemia
:hypercalcaemia rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Indication ;
                OpenPVSignal:has_ICD_code "E83.52" ;
                OpenPVSignal:has_MedDRA_code 10020583 ;
                OpenPVSignal:has_MedDRA_prefered_term "Hypercalcaemia" ;
                rdfs:label "hypercalcaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ibandronic_acid
:ibandronic_acid rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "M05BA06" ;
                 rdfs:label "ibandronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#intavenous_administration
:intavenous_administration rdf:type owl:NamedIndividual ,
                                    OpenPVSignal:Drug_Intake_Form ;
                           OpenPVSignal:refers_to_drug :pamindronicAcid ;
                           OpenPVSignal:refers_to_form_of_intake "injected (intraveneous)" ;
                           rdfs:label "intravenous administration" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#iridocyclitis
:iridocyclitis rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "H200" ;
               OpenPVSignal:has_MedDRA_code 10022941 ;
               OpenPVSignal:has_MedDRA_prefered_term "Iridocyclitis" ;
               rdfs:label "iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#iritis
:iritis rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "H209" ;
        OpenPVSignal:has_MedDRA_code 10022955 ;
        OpenPVSignal:has_MedDRA_prefered_term "Iritis" ;
        rdfs:label "iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#joint_pain
:joint_pain rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Indication ;
            OpenPVSignal:has_MedDRA_code 10023222 ;
            OpenPVSignal:has_MedDRA_prefered_term "Joint pain" ;
            rdfs:label "joint pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#lansoprazole
:lansoprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC03" ,
                                        "A02BC53" ,
                                        "A02BD02" ,
                                        "A02BD03" ,
                                        "A02BD07" ,
                                        "A02BD09" ,
                                        "A02BD10" ;
              rdfs:label "lansoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#lenalidomide
:lenalidomide rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "L04AX04" ;
              rdfs:label "lenalidomide" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#letrozole
:letrozole rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L02BG04" ;
           rdfs:label "letrozole" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#linezolid
:linezolid rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "J01XX08" ;
           rdfs:label "linezolid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#lisinopril
:lisinopril rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C09AA03" ,
                                      "C09BA03" ,
                                      "C09BB03" ,
                                      "C10BX07" ;
            rdfs:label "lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#literatureAndLabelling
:literatureAndLabelling rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Literature_information ;
                        mp:references :ref1 ,
                                      :ref2 ,
                                      :ref5 ,
                                      :ref6 ;
                        OpenPVSignal:has_content """The product literature does not refer to optic neuritis. As noted above, however, other inflammatory ocular reactions such as conjunctivitis, uveitis, scleritis, episcleritis, xanthopsia and orbital inflammation have been reported.1 There have also been  isolated reports of optic neuritis in association with pamidronic acid.5,6 Des Grottes et al described a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis.5 The authors noted that this possible complication had never been previously reported and, since the patient had a history of porphyria, it suggested that bisphosphonates should be administered cautiously in patients with this disease. Stack and Tarr reported three cases of optic neuritis and uveitis in association with bisphosphonates, one case with alendronate and the other two cases with pamidronic acid.6
Other bisphosphonates are also associated with inflammatory ocular  reactions.  Table  2 indicates the numbers of reports in VigiBase of these reactions. The number of reports of optic
neuritis with the bisphosphonates is indicative that the frequency of optic neuritis may be similar to that of other inflammatory ocular reactions.
""" ;
                        rdfs:label "literature and labelling" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#loratadine
:loratadine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "R06AX13" ;
            rdfs:label "loratadine" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#magnesiumHydroxide
:magnesiumHydroxide rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug ;
                    OpenPVSignal:has_ATC_code "A02AA04" ,
                                              "G04BX01" ;
                    rdfs:label "magnesium hydroxide" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#multipleMyeloma
:multipleMyeloma rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Indication ;
                 OpenPVSignal:has_ICD_code "C90.0" ;
                 OpenPVSignal:has_MedDRA_code 10028228 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Multiple myeloma" ;
                 rdfs:label "multiple myeloma" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#multipleSclerosis
:multipleSclerosis rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "G35" ;
                   OpenPVSignal:has_MedDRA_code 10028245 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Multiple sclerosis" ;
                   rdfs:label "multiple sclerosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#nicotinicAcid
:nicotinicAcid rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "C04AC01" ,
                                         "C10AD02" ;
               rdfs:label "nicotinic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#opticIschaemicNeuropathy
:opticIschaemicNeuropathy rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "H47019" ;
                          OpenPVSignal:has_MedDRA_code 10030924 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Optic ischaemic neuropathy" ;
                          rdfs:label "optic ischaemic neuropathy" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#opticNeuritis
:opticNeuritis rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "H469" ;
               OpenPVSignal:has_MedDRA_code 10030942 ;
               OpenPVSignal:has_MedDRA_prefered_term "Optic neuritis" ;
               rdfs:label "optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#optic_neuritis_and_drugs
:optic_neuritis_and_drugs rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Warning_Information ;
                          OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                          OpenPVSignal:refers_to_drug :amiodarone ,
                                                      :ethambutol ,
                                                      :linezolid ,
                                                      :phosphodiesteraseTypeFiveInhibitors ;
                          mp:references :ref4 ;
                          OpenPVSignal:has_content """A number of drugs have been implicated in the development of optic neuritis
including ethambutol in particular as well as linezolid, amiodarone and cGMP- specific phosphodiesterase type five inhibitors.4""" ;
                          rdfs:label "optic neuritis and drugs" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#optic_neuritis_pathobiology
:optic_neuritis_pathobiology rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Free_text_reporting_element ;
                             OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                             mp:references :ref2 ,
                                           :ref3 ,
                                           :ref4 ;
                             OpenPVSignal:has_content "Optic neuritis is a common inflammatory disease of the optic nerve.2 It may cause sudden, reduced vision in the affected eye. The exact cause of optic neuritis is unknown. Conditions that have been linked with optic neuritis include autoimmune diseases, bacterial, fungal, viral and respiratory infections and multiple sclerosis.3 A number of drugs have been implicated in the development of optic neuritis including ethambutol in particular as well as linezolid, amiodarone and cGMP- specific phosphodiesterase type five inhibitors.4" ;
                             rdfs:label "optic neuritis pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#orbitalInflammation
:orbitalInflammation rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "H0510" ;
                     OpenPVSignal:has_MedDRA_code 10075997 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Idiopathic orbital inflammation" ;
                     rdfs:label "orbital inflammation" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#osteolyticLesions
:osteolyticLesions rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Indication ;
                   OpenPVSignal:has_ICD_code "M89.50" ;
                   OpenPVSignal:has_MedDRA_code 10051544 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Osteolytic lesion" ;
                   rdfs:label "osteolytic lesions " .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#osteoporosis
:osteoporosis rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Indication ;
              OpenPVSignal:has_MedDRA_code 10031282 ;
              OpenPVSignal:has_MedDRA_prefered_term "Osteoporosis" ;
              rdfs:label "osteoporosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pamindronicAcid
:pamindronicAcid rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_mechanism :MechanismOfPamindronicAcid ;
                 OpenPVSignal:has_ATC_code "M05BA03" ;
                 rdfs:label "pamindronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pamindronicAcidAndOcularAdverseReactions
:pamindronicAcidAndOcularAdverseReactions rdf:type owl:NamedIndividual ,
                                                   OpenPVSignal:Warning_Information ;
                                          OpenPVSignal:refers_to_adverse_effect :autoimmune_disorder ,
                                                                                :conjunctivitis ,
                                                                                :episcleritis ,
                                                                                :orbitalInflammation ,
                                                                                :scleritis ,
                                                                                :uveitis ,
                                                                                :xanthopsia ;
                                          OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                          mp:references :ref1 ;
                                          mp:citation "Ocular adverse reactions which have been reported include conjunctivitis (common),uveitis (uncommon),scleritis,episcleritis and xanthopsia (very rare) and orbital inflammation (unknown frequency).1" ;
                                          rdfs:label "pamindronic acid and ocular adverse reactions" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pantoprazole
:pantoprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC02" ,
                                        "A02BD04" ,
                                        "A02BD11" ;
              rdfs:label "pantoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#paracetamol
:paracetamol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N02BE01" ;
             rdfs:label "paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#phosphodiesteraseTypeFiveInhibitors
:phosphodiesteraseTypeFiveInhibitors rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Drug ;
                                     OpenPVSignal:has_ATC_code "C01CE" ;
                                     rdfs:label "phosphodiesterase type five inhibitors" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :DiscussionAndConclusion ,
                                                   :IntroductionContent ,
                                                   :ReportsInVigibase ,
                                                   :SummaryContent ,
                                                   :optic_neuritis_pathobiology ;
          OpenPVSignal:is_supported_by_individual_case_report :report1 ,
                                                              :report10 ,
                                                              :report11 ,
                                                              :report2 ,
                                                              :report3 ,
                                                              :report4 ,
                                                              :report5 ,
                                                              :report6 ,
                                                              :report7 ,
                                                              :report8 ,
                                                              :report9 ;
          OpenPVSignal:is_supported_by_statistical_entity :IC025OfPamindronicAcidAndOpticNeuritis ,
                                                          :ICValueOfPamindronicAcidAndOpticNeuritis ,
                                                          :reportsOfPamindronicAcidAndOpticNeuritis ,
                                                          :reportsWithAlendronicAcidAndConjunctivitis ,
                                                          :reportsWithAlendronicAcidAndIridocyclitis ,
                                                          :reportsWithAlendronicAcidAndIritis ,
                                                          :reportsWithAlendronicAcidAndOpticNeuritis ,
                                                          :reportsWithAlendronicAcidAndScleritis ,
                                                          :reportsWithAlendronicAcidAndUveitis ,
                                                          :reportsWithBreastCancerAsIndication ,
                                                          :reportsWithClodronicAcidAndConjunctivitis ,
                                                          :reportsWithClodronicAcidAndIridocyclitis ,
                                                          :reportsWithClodronicAcidAndIritis ,
                                                          :reportsWithClodronicAcidAndOpticNeuritis ,
                                                          :reportsWithClodronicAcidAndScleritis ,
                                                          :reportsWithClodronicAcidAndUveitis ,
                                                          :reportsWithEtidronicAcidAndConjunctivitis ,
                                                          :reportsWithEtidronicAcidAndIridocyclitis ,
                                                          :reportsWithEtidronicAcidAndIritis ,
                                                          :reportsWithEtidronicAcidAndOpticNeuritis ,
                                                          :reportsWithEtidronicAcidAndScleritis ,
                                                          :reportsWithEtidronicAcidAndUveitis ,
                                                          :reportsWithFatalOutcome ,
                                                          :reportsWithIbandronicAcidAndConjunctivitis ,
                                                          :reportsWithIbandronicAcidAndIridocyclitis ,
                                                          :reportsWithIbandronicAcidAndIritis ,
                                                          :reportsWithIbandronicAcidAndOpticNeuritis ,
                                                          :reportsWithIbandronicAcidAndScleritis ,
                                                          :reportsWithIbandronicAcidAndUveitis ,
                                                          :reportsWithIntravenousAdministration ,
                                                          :reportsWithJointPainAsIndication ,
                                                          :reportsWithMultipleMyelomaAsIndication ,
                                                          :reportsWithOsteoporosisAsIndication ,
                                                          :reportsWithPamindronicAcidAndConjunctivitis ,
                                                          :reportsWithPamindronicAcidAndIridocyclitis ,
                                                          :reportsWithPamindronicAcidAndIritis ,
                                                          :reportsWithPamindronicAcidAndOpticNeuritis ,
                                                          :reportsWithPamindronicAcidAndScleritis ,
                                                          :reportsWithPamindronicAcidAndUveitis ,
                                                          :reportsWithPamindronicAcidBeingTheOnlySuspectDrug ,
                                                          :reportsWithRisedronicAcidAndConjunctivitis ,
                                                          :reportsWithRisedronicAcidAndIridocyclitis ,
                                                          :reportsWithRisedronicAcidAndIritis ,
                                                          :reportsWithRisedronicAcidAndOpticNeuritis ,
                                                          :reportsWithRisedronicAcidAndScleritis ,
                                                          :reportsWithRisedronicAcidAndUveitis ,
                                                          :reportsWithZoledronicAcidAndConjunctivitis ,
                                                          :reportsWithZoledronicAcidAndIridocyclitis ,
                                                          :reportsWithZoledronicAcidAndIritis ,
                                                          :reportsWithZoledronicAcidAndOpticNeuritis ,
                                                          :reportsWithZoledronicAcidAndScleritis ,
                                                          :reportsWithZoledronicAcidAndUveitis ,
                                                          :reports_from_Australia ,
                                                          :reports_from_Canada ,
                                                          :reports_from_New_Zealand ,
                                                          :reports_from_USA ,
                                                          :reports_with_age_info ,
                                                          :reports_with_no_recovery_outcome ,
                                                          :reports_with_time_to_onset_info ,
                                                          :reports_zoledronic_acid_as_a_suspect ,
                                                          <http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithrecovering/recoveredAsOutcome> ;
          mp:supportedByData :conditions_that_cause_optic_neuritis ,
                             :optic_neuritis_and_drugs ,
                             :pamindronicAcidAndOcularAdverseReactions ,
                             :reports_of_optic_neuritis_and_pamidronic_acid ;
          OpenPVSignal:initially_identified_on "01/11/2014" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#redBloodCellsCsfPositive
:redBloodCellsCsfPositive rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_MedDRA_code 10075562 ;
                          OpenPVSignal:has_MedDRA_prefered_term "CSF red blood cell count positive" ;
                          rdfs:label "red blood cells csf positive" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ref1
:ref1 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Electronic Medicines Compendium. Product Information for Aredia. Available from http://www. medicines.org.uk/EMC/medicine/7199/SPC/A RE DIA+Dry+Powder+15mg%2c+30mg+and+9 0mg/. Accessed: 3 December 2012." ;
      rdfs:label "ref1" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ref2
:ref2 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content " Longo DL, Fauci AS, Kasper DL, Hauser SL,Jameson JL, Loscalzo J, eds. Harrisonâ€™s Principles of Internal Medicine, 18th ed. McGraw Hill, New York, 2011." ;
      rdfs:label "ref2" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ref3
:ref3 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "PubMed Health. Optic neuritis. URL:http://www.ncbi. nlm.nih.gov/pubmedhealth/PMH0001750/. Accessed: 3December 2012." ;
      rdfs:label "ref3" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ref4
:ref4 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disor- ders. Drug Safety 2008; 31:127-41." ;
      rdfs:label "ref4" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ref5
:ref5 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Des Grottes JM, Schrooyen M, Dumon JC. Body JJ. Retrobulbar optic neuritis after pamidronate administra- tion in a patient with a history of cutaneous porphyria. Clin Rheumatol. 1997; 16:93-95." ;
      rdfs:label "ref5" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#ref6
:ref6 rdf:type owl:NamedIndividual ,
               OpenPVSignal:Bibliographic_reference ;
      OpenPVSignal:has_content "Stack R, Tarr K. Drug-induced optic neuritis and uveitis secondary to bisphosphonates. New Z Med J. 2006; 119." ;
      rdfs:label "ref6" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report1
:report1 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :opticNeuritis ,
                                               :redBloodCellsCsfPositive ,
                                               :visualImpairment ;
         OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                 :celecoxib ,
                                                 :clonazepam ,
                                                 :hydrochlorothiazide ,
                                                 :lansoprazole ,
                                                 :letrozole ,
                                                 :loratadine ,
                                                 :magnesiumHydroxide ,
                                                 :salbutamol ,
                                                 :sertraline ,
                                                 :sorbitol ,
                                                 :zolpidem ;
         OpenPVSignal:refers_to_patient :Patient1 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "report 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report10
:report10 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :fatality ,
                                                :opticNeuritis ,
                                                :visionBlurred ;
          OpenPVSignal:refers_to_patient :Patient10 ;
          OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
          OpenPVSignal:refers_to_secondary_suspect_drug :zoledronicAcid ;
          OpenPVSignal:refers_to_outcome_after_action "death" ;
          rdfs:label "report 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report11
:report11 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :headache ,
                                                :opticNeuritis ;
          OpenPVSignal:refers_to_patient :Patient11 ;
          OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "report 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report2
:report2 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :iritis ,
                                               :opticNeuritis ;
         OpenPVSignal:refers_to_concomitant_drug :amitriptyline ,
                                                 :clonidine ,
                                                 :paracetamol ;
         OpenPVSignal:refers_to_patient :Patient2 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "recovering" ;
         rdfs:label "report 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report3
:report3 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :opticIschaemicNeuropathy ,
                                               :opticNeuritis ;
         OpenPVSignal:refers_to_concomitant_drug :allopurinol ,
                                                 :amlodipine ,
                                                 :furosemide ,
                                                 :lisinopril ,
                                                 :nicotinicAcid ;
         OpenPVSignal:refers_to_patient :Patient3 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with sequelae" ;
         rdfs:label "report 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report4
:report4 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
         OpenPVSignal:refers_to_patient :Patient4 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "report 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report5
:report5 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :opticNeuritis ,
                                               :visionAbnormal ;
         OpenPVSignal:refers_to_patient :Patient5 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "report 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report6
:report6 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :fatality ,
                                               :opticNeuritis ;
         OpenPVSignal:refers_to_patient :Patient6 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "death" ;
         rdfs:label "report 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report7
:report7 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :blindness ,
                                               :opticNeuritis ,
                                               :retinalHaemorrhage ,
                                               :visionBlurred ,
                                               :vitreousFloaters ;
         OpenPVSignal:refers_to_patient :Patient7 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_secondary_suspect_drug :zoledronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "death" ;
         rdfs:label "report 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report8
:report8 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :blindness ,
                                               :multipleSclerosis ,
                                               :opticNeuritis ,
                                               :visualImpairment ;
         OpenPVSignal:refers_to_patient :Patient8 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_secondary_suspect_drug :zoledronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "report 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#report9
:report9 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
         OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                 :alprazolam ,
                                                 :dexamethasone ,
                                                 :duloxetine ,
                                                 :esomeprazole ,
                                                 :finasteride ,
                                                 :lenalidomide ,
                                                 :pantoprazole ,
                                                 :venlafaxine ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#paracetamol/oxycodoneHCl> ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#sulfamethoxazole/trimethoprim> ;
         OpenPVSignal:refers_to_patient :Patient9 ;
         OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
         OpenPVSignal:refers_to_secondary_suspect_drug :zoledronicAcid ;
         OpenPVSignal:refers_to_outcome_after_action "death" ;
         rdfs:label "report 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsOfPamindronicAcidAndOpticNeuritis
:reportsOfPamindronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                   OpenPVSignal:Reports_group ;
                                          OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                          OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                          OpenPVSignal:has_count 11 ;
                                          OpenPVSignal:has_count_of_men 2 ;
                                          OpenPVSignal:has_count_of_women 8 ;
                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                          rdfs:label "overall reports for pamindronic acid and optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithAlendronicAcidAndConjunctivitis
:reportsWithAlendronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                            OpenPVSignal:refers_to_drug :alendronic_acid ;
                                            OpenPVSignal:has_count 259 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with Alendronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithAlendronicAcidAndIridocyclitis
:reportsWithAlendronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                           OpenPVSignal:refers_to_drug :alendronic_acid ;
                                           OpenPVSignal:has_count 14 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Alendronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithAlendronicAcidAndIritis
:reportsWithAlendronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Reports_group ;
                                    OpenPVSignal:refers_to_adverse_effect :iritis ;
                                    OpenPVSignal:refers_to_drug :alendronic_acid ;
                                    OpenPVSignal:has_count 36 ;
                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                    rdfs:label "reports with Alendronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithAlendronicAcidAndOpticNeuritis
:reportsWithAlendronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                           OpenPVSignal:refers_to_drug :alendronic_acid ;
                                           OpenPVSignal:has_count 23 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Alendronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithAlendronicAcidAndScleritis
:reportsWithAlendronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                                OpenPVSignal:Reports_group ;
                                       OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                       OpenPVSignal:refers_to_drug :alendronic_acid ;
                                       OpenPVSignal:has_count 24 ;
                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                       rdfs:label "reports with Alendronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithAlendronicAcidAndUveitis
:reportsWithAlendronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                     OpenPVSignal:refers_to_drug :alendronic_acid ;
                                     OpenPVSignal:has_count 69 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with Alendronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithBreastCancerAsIndication
:reportsWithBreastCancerAsIndication rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:concerns_indication_for_use :breastCancer ;
                                     OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                     OpenPVSignal:has_count 1 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with breast cancer as indication" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithClodronicAcidAndConjunctivitis
:reportsWithClodronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                           OpenPVSignal:refers_to_drug :clodronic_acid ;
                                           OpenPVSignal:has_count 5 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Clodronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithClodronicAcidAndIridocyclitis
:reportsWithClodronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                   OpenPVSignal:Reports_group ;
                                          OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                          OpenPVSignal:refers_to_drug :clodronic_acid ;
                                          OpenPVSignal:has_count 0 ;
                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                          rdfs:label "reports with Clodronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithClodronicAcidAndIritis
:reportsWithClodronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:refers_to_adverse_effect :iritis ;
                                   OpenPVSignal:refers_to_drug :clodronic_acid ;
                                   OpenPVSignal:has_count 0 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   rdfs:label "reports with Clodronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithClodronicAcidAndOpticNeuritis
:reportsWithClodronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                   OpenPVSignal:Reports_group ;
                                          OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                          OpenPVSignal:refers_to_drug :clodronic_acid ;
                                          OpenPVSignal:has_count 1 ;
                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                          rdfs:label "reports with Clodronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithClodronicAcidAndScleritis
:reportsWithClodronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                      OpenPVSignal:refers_to_drug :clodronic_acid ;
                                      OpenPVSignal:has_count 0 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports with Clodronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithClodronicAcidAndUveitis
:reportsWithClodronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Reports_group ;
                                    OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                    OpenPVSignal:refers_to_drug :clodronic_acid ;
                                    OpenPVSignal:has_count 0 ;
                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                    rdfs:label "reports with Clodronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithEtidronicAcidAndConjunctivitis
:reportsWithEtidronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                           OpenPVSignal:refers_to_drug :etidronic_acid ;
                                           OpenPVSignal:has_count 14 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Etidronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithEtidronicAcidAndIridocyclitis
:reportsWithEtidronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                   OpenPVSignal:Reports_group ;
                                          OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                          OpenPVSignal:refers_to_drug :etidronic_acid ;
                                          OpenPVSignal:has_count 0 ;
                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                          rdfs:label "reports with Etidronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithEtidronicAcidAndIritis
:reportsWithEtidronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Reports_group ;
                                   OpenPVSignal:refers_to_adverse_effect :iritis ;
                                   OpenPVSignal:refers_to_drug :etidronic_acid ;
                                   OpenPVSignal:has_count 0 ;
                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                   rdfs:label "reports with Etidronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithEtidronicAcidAndOpticNeuritis
:reportsWithEtidronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                   OpenPVSignal:Reports_group ;
                                          OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                          OpenPVSignal:refers_to_drug :etidronic_acid ;
                                          OpenPVSignal:has_count 1 ;
                                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                          rdfs:label "reports with Etidronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithEtidronicAcidAndScleritis
:reportsWithEtidronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                      OpenPVSignal:refers_to_drug :etidronic_acid ;
                                      OpenPVSignal:has_count 0 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports with Etidronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithEtidronicAcidAndUveitis
:reportsWithEtidronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Reports_group ;
                                    OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                    OpenPVSignal:refers_to_drug :etidronic_acid ;
                                    OpenPVSignal:has_count 0 ;
                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                    rdfs:label "reports with Etidronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithFatalOutcome
:reportsWithFatalOutcome rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Reports_group ;
                         OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                         OpenPVSignal:has_count 4 ;
                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                         OpenPVSignal:refers_to_outcome_after_action "death" ;
                         rdfs:label "reports with fatal outcome " .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIbandronicAcidAndConjunctivitis
:reportsWithIbandronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                            OpenPVSignal:refers_to_drug :ibandronic_acid ;
                                            OpenPVSignal:has_count 41 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with Ibandronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIbandronicAcidAndIridocyclitis
:reportsWithIbandronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                           OpenPVSignal:refers_to_drug :ibandronic_acid ;
                                           OpenPVSignal:has_count 3 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Ibandronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIbandronicAcidAndIritis
:reportsWithIbandronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Reports_group ;
                                    OpenPVSignal:refers_to_adverse_effect :iritis ;
                                    OpenPVSignal:refers_to_drug :ibandronic_acid ;
                                    OpenPVSignal:has_count 8 ;
                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                    rdfs:label "reports with Ibandronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIbandronicAcidAndOpticNeuritis
:reportsWithIbandronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                           OpenPVSignal:refers_to_drug :ibandronic_acid ;
                                           OpenPVSignal:has_count 2 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Ibandronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIbandronicAcidAndScleritis
:reportsWithIbandronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                                OpenPVSignal:Reports_group ;
                                       OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                       OpenPVSignal:refers_to_drug :ibandronic_acid ;
                                       OpenPVSignal:has_count 10 ;
                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                       rdfs:label "reports with Ibandronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIbandronicAcidAndUveitis
:reportsWithIbandronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                     OpenPVSignal:refers_to_drug :ibandronic_acid ;
                                     OpenPVSignal:has_count 7 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with Ibandronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithIntravenousAdministration
:reportsWithIntravenousAdministration rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:is_related_with_drug_intake :intavenous_administration ;
                                      OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                      OpenPVSignal:has_count 8 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports with intravenous administration " .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithJointPainAsIndication
:reportsWithJointPainAsIndication rdf:type owl:NamedIndividual ,
                                           OpenPVSignal:Reports_group ;
                                  OpenPVSignal:concerns_indication_for_use :joint_pain ;
                                  OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                  OpenPVSignal:has_count 1 ;
                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                  rdfs:label "reports with joint pain as indication" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithMultipleMyelomaAsIndication
:reportsWithMultipleMyelomaAsIndication rdf:type owl:NamedIndividual ,
                                                 OpenPVSignal:Reports_group ;
                                        OpenPVSignal:concerns_indication_for_use :multipleMyeloma ;
                                        OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                        OpenPVSignal:has_count 2 ;
                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                        rdfs:label "reports with multiple myeloma as indication" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithOsteoporosisAsIndication
:reportsWithOsteoporosisAsIndication rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:concerns_indication_for_use :osteoporosis ;
                                     OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                     OpenPVSignal:has_count 1 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with osteoporosis as indication" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidAndConjunctivitis
:reportsWithPamindronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                      OpenPVSignal:Reports_group ;
                                             OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                             OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                             OpenPVSignal:has_count 94 ;
                                             OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                             rdfs:label "reports with pamindronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidAndIridocyclitis
:reportsWithPamindronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                            OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                            OpenPVSignal:has_count 6 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with pamindronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidAndIritis
:reportsWithPamindronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :iritis ;
                                     OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                     OpenPVSignal:has_count 19 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with pamindronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidAndOpticNeuritis
:reportsWithPamindronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                            OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                            OpenPVSignal:has_count 11 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with pamindronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidAndScleritis
:reportsWithPamindronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                                 OpenPVSignal:Reports_group ;
                                        OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                        OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                        OpenPVSignal:has_count 17 ;
                                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                        rdfs:label "reports with pamindronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidAndUveitis
:reportsWithPamindronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                      OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                      OpenPVSignal:has_count 44 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports with pamindronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithPamindronicAcidBeingTheOnlySuspectDrug
:reportsWithPamindronicAcidBeingTheOnlySuspectDrug rdf:type owl:NamedIndividual ,
                                                            OpenPVSignal:Reports_group ;
                                                   OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                                   OpenPVSignal:refers_to_primary_suspect_drug :pamindronicAcid ;
                                                   OpenPVSignal:has_count 7 ;
                                                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                   rdfs:label "reports with pamindronic acid being the only suspect drug" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithRisedronicAcidAndConjunctivitis
:reportsWithRisedronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                            OpenPVSignal:refers_to_drug :risedronic_acid ;
                                            OpenPVSignal:has_count 113 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with Risedronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithRisedronicAcidAndIridocyclitis
:reportsWithRisedronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                           OpenPVSignal:refers_to_drug :risedronic_acid ;
                                           OpenPVSignal:has_count 7 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Risedronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithRisedronicAcidAndIritis
:reportsWithRisedronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Reports_group ;
                                    OpenPVSignal:refers_to_adverse_effect :iritis ;
                                    OpenPVSignal:refers_to_drug :risedronic_acid ;
                                    OpenPVSignal:has_count 27 ;
                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                    rdfs:label "reports with Risedronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithRisedronicAcidAndOpticNeuritis
:reportsWithRisedronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                           OpenPVSignal:refers_to_drug :risedronic_acid ;
                                           OpenPVSignal:has_count 5 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Risedronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithRisedronicAcidAndScleritis
:reportsWithRisedronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                                OpenPVSignal:Reports_group ;
                                       OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                       OpenPVSignal:refers_to_drug :risedronic_acid ;
                                       OpenPVSignal:has_count 12 ;
                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                       rdfs:label "reports with Risedronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithRisedronicAcidAndUveitis
:reportsWithRisedronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                     OpenPVSignal:refers_to_drug :risedronic_acid ;
                                     OpenPVSignal:has_count 26 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with Risedronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithZoledronicAcidAndConjunctivitis
:reportsWithZoledronicAcidAndConjunctivitis rdf:type owl:NamedIndividual ,
                                                     OpenPVSignal:Reports_group ;
                                            OpenPVSignal:refers_to_adverse_effect :conjunctivitis ;
                                            OpenPVSignal:refers_to_drug :zoledronicAcid ;
                                            OpenPVSignal:has_count 330 ;
                                            OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                            rdfs:label "reports with Zoledronic acid and Conjunctivitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithZoledronicAcidAndIridocyclitis
:reportsWithZoledronicAcidAndIridocyclitis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :iridocyclitis ;
                                           OpenPVSignal:refers_to_drug :zoledronicAcid ;
                                           OpenPVSignal:has_count 53 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Zoledronic acid and Iridocyclitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithZoledronicAcidAndIritis
:reportsWithZoledronicAcidAndIritis rdf:type owl:NamedIndividual ,
                                             OpenPVSignal:Reports_group ;
                                    OpenPVSignal:refers_to_adverse_effect :iritis ;
                                    OpenPVSignal:refers_to_drug :zoledronicAcid ;
                                    OpenPVSignal:has_count 93 ;
                                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                    rdfs:label "reports with Zoledronic acid and Iritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithZoledronicAcidAndOpticNeuritis
:reportsWithZoledronicAcidAndOpticNeuritis rdf:type owl:NamedIndividual ,
                                                    OpenPVSignal:Reports_group ;
                                           OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                           OpenPVSignal:refers_to_drug :zoledronicAcid ;
                                           OpenPVSignal:has_count 16 ;
                                           OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                           rdfs:label "reports with Zoledronic acid and Optic neuritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithZoledronicAcidAndScleritis
:reportsWithZoledronicAcidAndScleritis rdf:type owl:NamedIndividual ,
                                                OpenPVSignal:Reports_group ;
                                       OpenPVSignal:refers_to_adverse_effect :scleritis ;
                                       OpenPVSignal:refers_to_drug :zoledronicAcid ;
                                       OpenPVSignal:has_count 24 ;
                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                       rdfs:label "reports with Zoledronic acid and Scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithZoledronicAcidAndUveitis
:reportsWithZoledronicAcidAndUveitis rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :uveitis ;
                                     OpenPVSignal:refers_to_drug :zoledronicAcid ;
                                     OpenPVSignal:has_count 92 ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "reports with Zoledronic acid and Uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_from_Australia
:reports_from_Australia rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Reports_group ;
                        OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                        OpenPVSignal:has_count 1 ;
                        OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Australia" ;
                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                        rdfs:label "reports from Australia" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_from_Canada
:reports_from_Canada rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Reports_group ;
                     OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                     OpenPVSignal:has_count 1 ;
                     OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Canada" ;
                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                     rdfs:label "reports from Canada" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_from_New_Zealand
:reports_from_New_Zealand rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                          OpenPVSignal:has_count 1 ;
                          OpenPVSignal:refers_to_country "http://dbpedia.org/resource/New_Zealand" ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "reports from New Zealand" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_from_USA
:reports_from_USA rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Reports_group ;
                  OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                  OpenPVSignal:has_count 8 ;
                  OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_States" ;
                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                  rdfs:label "reports from USA" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_of_optic_neuritis_and_pamidronic_acid
:reports_of_optic_neuritis_and_pamidronic_acid rdf:type owl:NamedIndividual ,
                                                        obo:OAE_0001197 ;
                                               OpenPVSignal:refers_to_adverse_effect :opticNeuritis ;
                                               OpenPVSignal:refers_to_drug :pamindronicAcid ;
                                               mp:references :ref5 ,
                                                             :ref6 ;
                                               OpenPVSignal:has_content "There have also been isolatedreports of optic neuritis in association with pamidronic acid.5,6 Des Grottes et al described a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis.5 The authors noted that this possible complication had never been previously reported and, since the patient had a history of porphyria, it suggested that bisphosphonates should be administered cautiously in patients with this disease. Stack and Tarr reported three cases of optic neuritis and uveitis in association with bisphosphonates, one case with alendronate and the other two cases with pamidronic acid.6" ;
                                               rdfs:label "reports of optic neuritis and pamidronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_with_age_info
:reports_with_age_info rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Reports_group ;
                       OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                       OpenPVSignal:has_count 5 ;
                       OpenPVSignal:has_max_age 88 ;
                       OpenPVSignal:has_median_age 65 ;
                       OpenPVSignal:has_min_age 12 ;
                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                       rdfs:label "reports with age info" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_with_no_recovery_outcome
:reports_with_no_recovery_outcome rdf:type owl:NamedIndividual ,
                                           OpenPVSignal:Reports_group ;
                                  OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                  OpenPVSignal:has_count 2 ;
                                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                  OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                                  rdfs:label "reports with no recovery outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_with_time_to_onset_info
:reports_with_time_to_onset_info rdf:type owl:NamedIndividual ,
                                          OpenPVSignal:Reports_group ;
                                 OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                 OpenPVSignal:time_to_onset :timeToOnsetInfo ;
                                 OpenPVSignal:has_count 2 ;
                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                 rdfs:label "reports with time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reports_zoledronic_acid_as_a_suspect
:reports_zoledronic_acid_as_a_suspect rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Reports_group ;
                                      OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                      OpenPVSignal:refers_to_secondary_suspect_drug :zoledronicAcid ;
                                      OpenPVSignal:has_count 4 ;
                                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                      rdfs:label "reports with zoledronic acid as a suspect" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#respiratoryInfection
:respiratoryInfection rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Adverse_Effect ;
                      OpenPVSignal:has_ICD_code "J069" ;
                      OpenPVSignal:has_MedDRA_code 10038700 ;
                      OpenPVSignal:has_MedDRA_prefered_term "Respiratory infection" ;
                      rdfs:label "respiratory infection" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#retinalHaemorrhage
:retinalHaemorrhage rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "H356" ;
                    OpenPVSignal:has_MedDRA_code 10038867 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Retinal haemorrhage" ;
                    rdfs:label "retinal haemorrhage" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#risedronic_acid
:risedronic_acid rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "M05BA07" ;
                 rdfs:label "risedronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#salbutamol
:salbutamol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "R03AC02" ,
                                      "R03AK04" ,
                                      "R03AL02" ,
                                      "R03CC02" ;
            rdfs:label "salbutamol" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#scleritis
:scleritis rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "H15019" ;
           OpenPVSignal:has_MedDRA_code 10039705 ;
           OpenPVSignal:has_MedDRA_prefered_term "Scleritis" ;
           rdfs:label "scleritis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#sertraline
:sertraline rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AB06" ;
            rdfs:label "sertraline" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#sorbitol
:sorbitol rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "A06AD18" ,
                                    "A06AG07" ,
                                    "B05CX02" ,
                                    "V04CC01" ;
          rdfs:label "sorbitol" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#timeToOnsetInfo
:timeToOnsetInfo rdf:type owl:NamedIndividual ,
                          <http://www.w3.org/2006/time#DurationDescription> ;
                 OpenPVSignal:has_content "Time to onset was reported with clarity in only two of the reports and ranged from the same day that the drug was most recently administered to one day after admi- nistration. For a drug which is administered once every three or four weeks, as it is in the treatment of bone metastases which is the indication in the majority of reports, time to onset is most meaningful when related to the most recent administration." ;
                 rdfs:label "time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#tumour_induced_hypercalcaemia
:tumour_induced_hypercalcaemia rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Indication ;
                               OpenPVSignal:has_MedDRA_code 10020584 ;
                               OpenPVSignal:has_MedDRA_prefered_term "Hypercalcaemia of malignancy" ;
                               rdfs:label "tumour induced hypercalcaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#usageOfPamindronicAcid
:usageOfPamindronicAcid rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Drug_Usage ;
                        OpenPVSignal:concerns_indication_for_use :boneMetastases ,
                                                                 :bonePain ,
                                                                 :breastCancer ,
                                                                 :hypercalcaemia ,
                                                                 :multipleMyeloma ,
                                                                 :osteolyticLesions ,
                                                                 :tumour_induced_hypercalcaemia ,
                                                                 <http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pagetâ€™sDiseaseOfBone> ;
                        OpenPVSignal:is_related_with_drug_intake :intavenous_administration ;
                        OpenPVSignal:refers_to_drug :pamindronicAcid ;
                        rdfs:label "usage of pamindronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#uveitis
:uveitis rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "H44139" ;
         OpenPVSignal:has_MedDRA_code 10046851 ;
         OpenPVSignal:has_MedDRA_prefered_term "Uveitis" ;
         rdfs:label "uveitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#venlafaxine
:venlafaxine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N06AX16" ;
             rdfs:label "venlafaxine" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#viralInfection
:viralInfection rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "B349" ;
                OpenPVSignal:has_MedDRA_code 10047461 ;
                OpenPVSignal:has_MedDRA_prefered_term "Viral infection" ;
                rdfs:label "viral infection" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#visionAbnormal
:visionAbnormal rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "H54" ;
                OpenPVSignal:has_MedDRA_code 10047571 ;
                OpenPVSignal:has_MedDRA_prefered_term "Visual impairment" ;
                rdfs:label "vision abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#visionBlurred
:visionBlurred rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "H538" ;
               OpenPVSignal:has_MedDRA_code 10047513 ;
               OpenPVSignal:has_MedDRA_prefered_term "Vision blurred" ;
               rdfs:label "vision blurred" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#visualImpairment
:visualImpairment rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "H54" ;
                  OpenPVSignal:has_MedDRA_code 10047571 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Visual impairment" ;
                  rdfs:label "visual impairment" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#vitreousFloaters
:vitreousFloaters rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "H43399" ;
                  OpenPVSignal:has_MedDRA_code 10047654 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Vitreous floaters" ;
                  rdfs:label "vitreous floaters" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#xanthopsia
:xanthopsia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "H5350" ;
            OpenPVSignal:has_MedDRA_code 10048216 ;
            OpenPVSignal:has_MedDRA_prefered_term "Xanthopsia" ;
            rdfs:label "xanthopsia" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#zoledronicAcid
:zoledronicAcid rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "M05BA08" ;
                rdfs:label "zoledronic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#zolpidem
:zolpidem rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N05CF02" ;
          rdfs:label "zolpidem" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pagetâ€™sDiseaseOfBone
<http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#pagetâ€™sDiseaseOfBone> rdf:type owl:NamedIndividual ,
                                                                                                            OpenPVSignal:Indication ;
                                                                                                   OpenPVSignal:has_ICD_code "M88.9" ;
                                                                                                   OpenPVSignal:has_MedDRA_code 10033363 ;
                                                                                                   OpenPVSignal:has_MedDRA_prefered_term "Paget's disease of bone" ;
                                                                                                   rdfs:label "pagetâ€™s disease of bone" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#paracetamol/oxycodoneHCl
<http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#paracetamol/oxycodoneHCl> rdf:type owl:NamedIndividual ,
                                                                                                                OpenPVSignal:Drug ;
                                                                                                       OpenPVSignal:has_ATC_code "N02AJ17" ;
                                                                                                       rdfs:label "paracetamol / oxycodone HCl" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithrecovering/recoveredAsOutcome
<http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#reportsWithrecovering/recoveredAsOutcome> rdf:type owl:NamedIndividual ,
                                                                                                                                OpenPVSignal:Reports_group ;
                                                                                                                       OpenPVSignal:is_subgroup_of :reportsOfPamindronicAcidAndOpticNeuritis ;
                                                                                                                       OpenPVSignal:has_count 4 ;
                                                                                                                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                                                                                       OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                                                                                                                       rdfs:label "reports with recovering/recovered as outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#sulfamethoxazole/trimethoprim
<http://purl.org/OpenPVSignal/Signals/2014_5_pamindronic_acid_optic_neuritis#sulfamethoxazole/trimethoprim> rdf:type owl:NamedIndividual ,
                                                                                                                     OpenPVSignal:Drug ;
                                                                                                            OpenPVSignal:has_ATC_code "J01EE" ;
                                                                                                            rdfs:label "sulfamethoxazole/trimethoprim" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
